AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Fetoscopic Endoluminal Tracheal Occlusion

RecruitingNAAges 18 Years - anyFemaleChildren's Hospitals and Clinics of Minnesota
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a single site pilot trial to study the feasibility of Fetoscopic Endoluminal Tracheal Occlusion (FETO) therapy in the most severe group of fetuses with congenital diaphragmatic hernia (CDH) at Midwest Fetal Care Center, a collaboration between Allina Health and Children's Minnesota. This procedure aims to increase fetal lung volume before birth and improve survival after birth. This study will enroll 10 pregnant people and their baby who meet study criteria.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. A subject is defined as a female (18 years or older) who is pregnant. 2. The pregnancy must be a singleton pregnancy. 3. The CDH must be left-sided. 4. The CDH must be severe (Observed to Expected Lung to Head Ratio - O/E LHR - \< 25% from U/S measurements). 5. No associated lethal anomalies (other than the CDH), no pathogenic variants on microarray, and no pathologic findings on karyotype. 6. Fetal echocardiogram with changes expected with CDH and no major structural cardiac defects. 7. Gestational age at time of balloon placement between and including 27 weeks 0 days and 29 weeks 6 days. 8. Cervix length longer than 20 mm at pre-balloon placement evaluation. 9. Acceptance of responsibility to stay locally (within 15 minutes) of MWFCC and Children's Minnesota - Minneapolis. 10. Written consent must be obtained. 11. Must meet psychosocial criteria including appropriate family/friend support during stay with balloon in place (cannot stay without additional helper), no current illicit drug use, no over-the-counter drug abuse, and no ineffectively treated DSM-IV diagnoses. Exclusion Criteria: 1. Twin or higher order gestation 2. Not able to consent 3. Right-sided or bilateral CDH 4. Additional fetal or genetic abnormalities that would impact care after delivery or be known to have an impact on outcome 5. Maternal isoimmunization or neonatal alloimmune thrombocytopenia 6. Balloon not able to be placed prior to 30 weeks gestation 7. CDH O/E LHR 25% or greater 8. Maternal factors precluding safe fetal surgery (maternal cardiac findings not safe for anesthesia, maternal morbid obesity precluding safe usage of the equipment required for entry into the uterus, spontaneous preterm delivery prior to 36 weeks) 9. Maternal HIV, Hepatitis B with positive surface antigen, Hepatitis C with presence of virus in maternal blood due to risks of fetal transmission during procedures 10. Short cervix (20 mm or less) 11. History of incompetent cervix or uterine anomaly predisposing to preterm labor 12. Significant placental abnormalities (abruption, chorioangioma, accrete) known at the time of enrollment and/or surgery 13. History of natural rubber latex allergy 14. No safe or feasible fetoscopic approach to balloon placement 15. Inability to relocate to within 15 minutes of MWFCC/Children's Minnesota
๐Ÿ’Š

What it tests

  • FETO therapy
๐Ÿ“

Where

1 site
Midwest Fetal Care Center
Minneapolis, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy